Daily Stock Analysis, ACRS, Aclaris Therapeutics Inc, priceseries

Aclaris Therapeutics Inc. Daily Stock Analysis
Stock Information
Open
20.29
Close
20.13
High
20.51
Low
19.80
Previous Close
20.22
Daily Price Gain
-0.09
YTD High
26.25
YTD High Date
Jan 12, 2018
YTD Low
18.46
YTD Low Date
Feb 9, 2018
YTD Price Change
-4.90
YTD Gain
-19.58%
52 Week High
33.25
52 Week High Date
Mar 8, 2017
52 Week Low
18.46
52 Week Low Date
Feb 9, 2018
52 Week Price Change
-7.75
52 Week Gain
-27.80%
Company Information
Stock Symbol
ACRS
Exchange
NasdaqGS
Company URL
http://www.aclaristx.com
Company Phone
484-321-5554
CEO
Neal S. Walker
Headquarters
Pennsylvania
Business Address
SUITE 400, 101 LINDENWOOD DRIVE, MALVERN, PA 19355
Sector
Equity
Industry Category
Drugs
Industry Group
Biotechnology
CIK
0001557746
About

Aclaris Therapeutics, Inc. is a clinical-stage specialty pharmaceutical company, which engages in identifying, developing and commercializing novel drugs to address unmet needs in dermatology. It also pursues the development of topical agents for the treatment and prevention of a number of medical and cosmetic indications. The company was founded by Neal S. Walker, Frank Ruffo, Kamil Ali-Jackson, Christopher V. Powala and Stuart D. Shanler in July 2012 and is headquartered in Malvern, PA.

Description

Developing a proprietary hydrogen peroxide treatment for common skin lesions.